Stark, K.* ; Philippi, V.* ; Stockhausen, S.* ; Busse, J.* ; Antonelli, A.* ; Miller, M.* ; Schubert, I.* ; Hoseinpour, P.* ; Chandraratne, S.* ; von Brühl, M.L.* ; Gärtner, F.* ; Lorenz, M.* ; Agresti, A.* ; Coletti, R.* ; Antoine, D.J.* ; Heermann, R.* ; Jung, K.* ; Reese, S.* ; Laitinen, I.* ; Schwaiger, M.* ; Walch, A.K. ; Sperandio, M.* ; Nawroth, P.P.* ; Reinhardt, C.* ; Jäckel, S.* ; Bianchi, M.E.* ; Massberg, S.*
Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.
Blood 128, 2435-2449 (2016)
Deep venous thrombosis (DVT) is one of the most common cardiovascular diseases, but its pathophysiology remains incompletely understood. While sterile inflammation has recently been shown to boost coagulation during DVT, the underlying molecular mechanisms are not fully resolved, which could potentially identify new anti-inflammatory approaches to prophylaxis and therapy of DVT. Using a mouse model of venous thrombosis induced by flow reduction in the vena cava inferior we identified blood-derived high-mobility group box 1 protein (HMGB1) - a prototypical mediator of sterile inflammation - to be a master regulator of the prothrombotic cascade involving platelets and myeloid leukocytes fostering occlusive DVT formation. Transfer of platelets into Hmgb1(-/-) chimeras showed that this cell type is the major source of HMGB1, exposing reduced HMGB1 on their surface upon activation thereby enhancing the recruitment of monocytes. Activated leukocytes in turn support oxidation of HMGB1 unleashing its prothrombotic activity and promoting platelet aggregation. This potentiates the amount of HMGB1 and further nurtures the accumulation and activation of monocytes through RAGE and TLR2, leading to local delivery of monocyte-derived tissue factor and cytokines. Moreover, disulfide HMGB1 facilitates formation of prothrombotic neutrophil extracellular traps (NETs) mediated by RAGE, exposing additional HMGB1 on their extracellular DNA strands. Eventually, a vicious circle of coagulation and inflammation is set in motion leading to obstructive DVT formation. Therefore, platelet derived disulfide HMGB1 is a central mediator of the sterile inflammatory process in venous thrombosis and could be an attractive target for an anti-inflammatory approach for DVT prophylaxis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Mobility Group Box-1; Glycation End-products; Neutrophil Extracellular Traps; Green Fluorescent Protein; Deep-vein Thrombosis; Sterile Inflammation; Innate Immunity; In-vivo; Dependent Mechanisms; Ischemia-reperfusion
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2016
Prepublished im Jahr
HGF-Berichtsjahr
2016
ISSN (print) / ISBN
0006-4971
e-ISSN
1528-0020
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 128,
Heft: 20,
Seiten: 2435-2449
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
American Society of Hematology
Verlagsort
Washington
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-500390-001
Förderungen
Copyright
Erfassungsdatum
2016-09-01